Seminars
Feb 11, 2026
PDF Seminar
C-terminal tail of MAVS dictates organelle targeting and innate immune response - Dr. Tak Wang Terence Lee (Post-doctoral Fellow)
School of Biomedical Sciences cordially invites you to join the following Post-doctoral Fellow (PDF) Seminar:
Date: 11 February 2026 (Wednesday)
Time: 4:00 pm – 4:30 pm
Venue: Seminar Room 2, G/F, Laboratory Block, 21 Sassoon Road
Host: Dr. Xiang Fang & Dr. Yolanda Liu
Light refreshments will be served. Please register via the below link by 10 February 2026 (Tuesday):
Registration: https://hku.au1.qualtrics.com/jfe/form/SV_a4ZB02clN09kqLs
C-terminal tail of MAVS dictates organelle targeting and innate immune response
Dr. Tak Wang Terence Lee (Post-doctoral Fellow)
[Supervisor: Professor Dong-Yan Jin]
MAVS is a mitochondrial and peroxisomal protein that adapts innate RNA sensing by RIG-I-like receptors to downstream signalling. MAVS aggregation is required for the propagation of activation signal, however whether this requirement varies with respect to subcellular localization remains unclear. We identified that MAVS aggregation is required for innate immune signalling triggered by mitochondrial but not peroxisomal MAVS. An aggregation-deficient mutant of peroxisomal MAVS retained its ability to induce type I interferon production. We further demonstrated that the magnitude of the activation signal and the distribution of MAVS to mitochondria and peroxisomes are governed by the tail charge at the C-terminus of MAVS. An increase in tail charge directs MAVS to peroxisomes predominantly, leading to a more modest activation of innate immune signalling. These results suggest that MAVS displays compartment-specific properties that are mechanistically and functionally distinct in RNA sensing.
All are welcome.
New Releases
Mar 9, 2026
HKUMed demonstrates that 'cloaked' and safe human stem cells work, paving the way for off-the-shelf transplants without immune rejection
Feb 11, 2026
HKUMed School of Biomedical Sciences and Merck Pharmaceutical (Hong Kong) sign MoU to advance biomedical education and talent development
Nov 25, 2025
HKUMed cracks gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases
Nov 6, 2025